Free Daily Analysis

Stock Trend Analysis Report

Prepared for you on Thursday, June 19, 2025.

Atea Pharmaceuticals, Inc. - common stock (NASDAQ:AVIR)

Long-Term Uptrend (+90) - AVIR is in a strong uptrend that is likely to continue. While AVIR is showing intraday weakness, it remains in the confines of a bullish trend. Traders should use caution and utilize a stop order.

Is it time to buy, sell, or avoid AVIR?

MarketClub looks at technical strength and momentum to determine if the timing is right for AVIR.

Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.

NASDAQ_AVIR
Open High Low AVIR Price Change
3.200 3.315 3.180 3.205 -0.005
Entry Signal

MarketClub’s Trade Triangles for AVIR

long term up The long-term trend has been UP since Jun 10th, 2025 at 3.2900

intermediate term up The intermediate-term trend has been UP since May 27th, 2025 at 3.0100

short term up The short-term trend has been UP since Jun 17th, 2025 at 3.2793

Smart Scan Analysis for AVIR

Based on our trend formula, AVIR is rated as a +90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).

+90
Smart Scan Analysis for AVIR
Strong Downtrend Sideways Strong Uptrend
Open High Low Price Change
3.200 3.315 3.180 3.205 -0.005
Prev. Close Volume Bid Ask Time
3.210 304841 2025-06-18 15:59:40
52wk High4.14552wk High Date2024-09-17
52wk Low2.45552wk Low Date2025-05-15
Average Volume391,091Shares Outstanding85,579
Assets439,964,000MLiabilities28,880,000M
P/E Ratio10.1515
Get a free daily analysis and signals for Atea Pharmaceuticals, Inc. - common stock (AVIR) - Request Your Free Report.